Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

GSK gets positive EMA panel opinion for Respiratory syncytial virus older adult vaccine

Ruchika Sharma29 April 2023 2:30 PM IST

GSK's RSV older adult vaccine candidate contains a recombinant subunit RSV prefusion F glycoprotein antigen (RSVPreF3) combined with the Company's...

USFDA panel backs restricted use of AstraZeneca Prostrate cancer drug

Ruchika Sharma29 April 2023 12:30 PM IST

Lynparza belongs to a class of drugs called PARP inhibitors, which include Clovis Oncology's Rubraca and GSK Plc's Zejula.

Biocon unveils Liraglutide for diabetes, obesity in Netherlands

Biocon Biologics Bengaluru facility gets EU GMP certification for Bevacizumab

Ruchika Sharma29 April 2023 11:47 AM IST

Bangalore: Biocon Biologics’ integrated, multi-product, monoclonal antibodies (mAbs) Drug Substance manufacturing facility (B3) at Biocon Park,...

Roche unveils new PCR test to improve Vaginitis Diagnosis in countries following CE Mark

Roche blood cancer drug Columvi gets EMA panel recommendation for EU approval

Ruchika Sharma28 April 2023 5:26 PM IST

Basel: Roche has announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of...

Syngene profit after tax rises 21 percent at Rs 179 crore in Q4

Ruchika Sharma28 April 2023 2:30 PM IST

Revenue from operations rose to Rs 3,193 crore in FY23 as compared with Rs 2,604 in 2021-22 fiscal.

US not liable in Moderna COVID vaccine patent case, says Second judge

Ruchika Sharma28 April 2023 1:30 PM IST

A Moderna spokesperson said in a statement that the company "respectfully disagrees" with the decision and is confident that discovery will support...

Sanofi gets approval for 2 rare hematologic diseases medicines in China

Sanofi concludes acquisition of Provention Bio

Ruchika Sharma28 April 2023 12:30 PM IST

Paris: Sanofi has announced the completion of its acquisition of Provention Bio, Inc.. The acquisition adds TZIELD (teplizumab-mzwv), a fully owned,...

USFDA nod to Padcev plus Keytruda for certain patients with Bladder cancer: Pfizer, Astellas Pharma

Pfizer gets USFDA approval for 20-valent Pneumococcal Conjugate Vaccine PREVNAR 20 for infants, children

Ruchika Sharma28 April 2023 11:43 AM IST

PREVNAR 20 builds on Pfizer's approved PREVNAR 13 vaccine, and includes seven additional serotypes (8, 10A, 11A, 12F, 15B, 22F and 33F) shown to be...

Cabinet nod to National Medical Devices Policy, 2023

Ruchika Sharma27 April 2023 3:30 PM IST

The National Medical Devices Policy, 2023 is expected to facilitate an orderly growth of the medical device sector to meet the public health...

GSK beats expectations for Q1 revenue, profit

Ruchika Sharma27 April 2023 2:30 PM IST

London: GSK on Wednesday beat expectations for its first-quarter revenue and profit, helped by sales of its blockbuster shingles vaccine Shingrix.The...

Import Nod on Hold Over False Positives, Tissue Detection: CDSCO Panel Seeks More Data on Medtronics PTeye Device

Medtronic blasts rival's 'threadbare' antitrust lawsuit

Ruchika Sharma27 April 2023 1:30 PM IST

The lawsuit filed in February accused Medtronic, which recorded more than $31 billion in revenue in 2022, of selling its "advanced bipolar devices"...

Venus Remedies bags UK MHRA marketing nod for chemotherapy drug Cisplatin

Ruchika Sharma27 April 2023 12:29 PM IST

Chandigarh: Venus Remedies Ltd, a provider of cancer drugs worldwide, has secured marketing authorisation from the UK for Cisplatin, a...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok